118 related articles for article (PubMed ID: 26812836)
1. Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics).
Fricke-Galindo I; Jung-Cook H; LLerena A; López-López M
Drug Metab Pers Ther; 2016 Jun; 31(2):61-81. PubMed ID: 26812836
[TBL] [Abstract][Full Text] [Related]
2. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in Central American healthy volunteers: interethnic variability.
Céspedes-Garro C; Naranjo ME; Ramírez R; Serrano V; Fariñas H; Barrantes R; LLerena A;
Drug Metab Pers Ther; 2015 Mar; 30(1):19-31. PubMed ID: 25490028
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 genetic polymorphisms of Mexican indigenous populations.
Sosa-Macías M; Llerena A
Drug Metabol Drug Interact; 2013; 28(4):193-208. PubMed ID: 24145057
[TBL] [Abstract][Full Text] [Related]
5. CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.
Saldaña-Cruz AM; León-Moreno LC; Sánchez-Corona J; Santiago DA; Mendoza-Carrera F; Castro-Martínez XH; García-Zapién AG; Morán-Moguel MC; Flores-Martínez SE
Genet Test Mol Biomarkers; 2016 Nov; 20(11):702-709. PubMed ID: 27617498
[TBL] [Abstract][Full Text] [Related]
6. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
[TBL] [Abstract][Full Text] [Related]
7. Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.
Villegas-Torres B; Sánchez-Girón F; Jaramillo-Villafuerte K; Soberón X; Gonzalez-Covarrubias V
Gene; 2015 Mar; 558(2):235-40. PubMed ID: 25560189
[TBL] [Abstract][Full Text] [Related]
8. CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas.
López-López M; Peñas-Lledó E; Dorado P; Ortega A; Corona T; Ochoa A; Yescas P; Alonso E; LLerena A
Pharmacogenomics; 2014; 15(15):1859-65. PubMed ID: 25495408
[TBL] [Abstract][Full Text] [Related]
9. CYP2C9 allele frequency differences between populations of Mexican-Mestizo, Mexican-Tepehuano, and Spaniards.
Dorado P; Sosa-Macias MG; Peñas-Lledó EM; Alanis-Bañuelos RE; Wong ML; Licinio J; Lares-Asseff I; Llerena A
Pharmacogenomics J; 2011 Apr; 11(2):108-12. PubMed ID: 20458343
[TBL] [Abstract][Full Text] [Related]
10. Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers.
Mirzaev K; Abdullaev S; Akmalova K; Sozaeva J; Grishina E; Shuev G; Bolieva L; Sozaeva M; Zhuchkova S; Gimaldinova N; Sidukova E; Serebrova S; Asoskova A; Shein A; Poptsova M; Suleymanov S; Burashnikova I; Shikaleva A; Kachanova A; Fedorinov D; Sychev D
Pharmacogenomics; 2020 Jul; 21(10):677-694. PubMed ID: 32539557
[No Abstract] [Full Text] [Related]
11. Genetic variability of CYP2C9*2 and CYP2C9*3 in seven indigenous groups from Mexico.
Sánchez-Pozos K; Rivera-Santiago C; García-Rodríguez MH; Ortiz-López MG; Peña-Espinoza BI; Granados-Silvestre MLÁ; Llerena A; Menjívar M
Pharmacogenomics; 2016 Nov; 17(17):1881-1889. PubMed ID: 27790940
[TBL] [Abstract][Full Text] [Related]
12. Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers.
Fricke-Galindo I; Ortega-Vázquez A; Monroy-Jaramillo N; Dorado P; Jung-Cook H; Peñas-Lledó E; LLerena A; López-López M
Pharmacogenomics; 2016 Nov; 17(17):1913-1930. PubMed ID: 27790929
[TBL] [Abstract][Full Text] [Related]
13. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico.
Lazalde-Ramos BP; Martínez-Fierro Mde L; Galaviz-Hernández C; Garza-Veloz I; Naranjo ME; Sosa-Macías M; Llerena A
Pharmacogenomics; 2014 Feb; 15(3):339-48. PubMed ID: 24533713
[TBL] [Abstract][Full Text] [Related]
15. Interethnic relationships of CYP2D6 variants in native and Mestizo populations sharing the same ecosystem.
Perez-Paramo YX; Hernandez-Cabrera F; Dorado P; Llerena A; Muñoz-Jimenez S; Ortiz-Lopez R; Rojas-Martinez A
Pharmacogenomics; 2015; 16(7):703-12. PubMed ID: 25941923
[TBL] [Abstract][Full Text] [Related]
16. Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.
LLerena A; Naranjo ME; Rodrigues-Soares F; Penas-LLedó EM; Fariñas H; Tarazona-Santos E
Expert Opin Drug Metab Toxicol; 2014 Nov; 10(11):1569-83. PubMed ID: 25316321
[TBL] [Abstract][Full Text] [Related]
17. Influence of admixture components on CYP2C9*2 allele frequency in eight indigenous populations from Northwest Mexico.
Sosa-Macías M; Lazalde-Ramos BP; Galaviz-Hernández C; Rangel-Villalobos H; Salazar-Flores J; Martínez-Sevilla VM; Martínez-Fierro ML; Dorado P; Wong ML; Licinio J; LLerena A
Pharmacogenomics J; 2013 Dec; 13(6):567-72. PubMed ID: 23358499
[TBL] [Abstract][Full Text] [Related]
18. HLA class II alleles in the Otomi population of the Mezquital Valley: a genetic approach to the history of interethnic migrations in the Mexican Central Plateau.
Juárez-Martín AI; González-Sobrino BZ; Olvera ÁE; Falfán-Valencia R
Hum Biol; 2014; 86(3):167-84. PubMed ID: 25836745
[TBL] [Abstract][Full Text] [Related]
19. Identifying drugs needing pharmacogenetic monitoring in a Korean hospital.
Kim YM; Yoo SH; Kang RY; Kim MJ; Bae YY; Lee YK; Jeon SJ; Chon KJ; Shin SM; Kim SG; Park KH; Son IJ
Am J Health Syst Pharm; 2007 Jan; 64(2):166-75. PubMed ID: 17215467
[TBL] [Abstract][Full Text] [Related]
20. Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos.
Contreras AV; Monge-Cazares T; Alfaro-Ruiz L; Hernandez-Morales S; Miranda-Ortiz H; Carrillo-Sanchez K; Jimenez-Sanchez G; Silva-Zolezzi I
Pharmacogenomics; 2011 May; 12(5):745-56. PubMed ID: 21391885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
